Composition and organic light-emitting device including the same

US11760769B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11760769-B2
Application numberUS-201916669765-A
CountryUS
Kind codeB2
Filing dateOct 31, 2019
Priority dateMar 29, 2019
Publication dateSep 19, 2023
Grant dateSep 19, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A composition including a first compound including a compound represented by Formula 1, a second compound including a compound represented by Formula 2, and a third compound including a compound represented by Formula 3, and an organic light-emitting device including the composition: wherein the description of Formulae 1 to 3 are the same as described in the specification.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising: a first compound, a second compound, and a third compound, wherein the first compound comprises a compound represented by Formula 1, the second compound comprises a compound represented by Formula 2, and the third compound comprises a compound represented by Formula 3: wherein Y 2 in Formula 1 is C, a group represented by in Formula 1 is a group represented by Formula A(1): wherein, in Formula A(1), R 9 and R 11 are each independently a C 1 -C 20 alkyl group, a C 3 -C 10 cycloalkyl group, a C 2 -C 10 heterocycloalkyl group, or a phenyl group, each unsubstituted or substituted with deuterium, a C 1 -C 20 alkyl group, a C 3 -C 10 cycloalkyl group, a C 2 -C 10 heterocycloalkyl group, a phenyl group, or any combination thereof, and R 10 and R 12 are each independently hydrogen or deuterium, *′indicates a binding site to Ir in Formula 1 , and *″ indicates a binding site to a neighboring atom in Formula 1 , Ar 1 , Ar 2 , and Ar n in Formulae 2 and 3 are each independently a C 5 -C 60 carbocyclic group which is unsubstituted or substituted with at least one R 61 or a C 1 -C 60 heterocyclic group which is unsubstituted or substituted with at least one R 61 , Ar 5 and A 12 in Formulae 2 and 3 are each independently a single bond, a C 5 -C 60 carbocyclic group which is unsubstituted or substituted with at least one R 65 , or a C 1 -C 60 heterocyclic group which is unsubstituted or substituted with at least one R 65 , or does not exist, n in Formula 2 is 1, 2, or 3, and when n is 1, Ar 5 does not exist, p in Formula 3 is 1, 2, or 3, and when p is 1, Ar 12 does not exist, a1 and a2 in Formula 2 are each independently an integer from 0 to 5, and the sum of a1 and a2 is 1 or more, ring CY 2 and ring CY 3 in Formula 2 are each independently a C 5 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, and ring CY 2 and ring CY 3 are optionally linked to each other with a C 5 -C 60 carbocyclic group which is unsubstituted or substituted with at least one R 66 or a C 1 -C 60 heterocyclic group which is unsubstituted or substituted with at least one R 66 therebetween, Het1 in Formula 3 is a π electron-depleted nitrogen-containing C 1 -C 60 cyclic group, a11 and m in Formula 3 are each independently an integer from 1 to 10, R 1 to R 8 , A 1 to A 7 , R 20 , R 30 , R 61 , R 65 , R 66 , R 70 , and R 80 in Formulae 1 to 3 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, —SF 5 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazino group, a hydrazono group, a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —N(Q 1 )(Q 2 ), —Si(Q 3 )(Q 4 )(Qs), —Ge(Q 3 )(Q 4 )(Qs), —B(Q 6 )(Q 7 ), —P(═O)(Qs)(Q 9 ), or —P(Qs)(Q 9 ), provided that at least one of R 1 to Rs is a fluoro group (—F), b2, b3, b7, and b8 in Formulae 2 and 3 are each independently an integer from 0 to 20, when b2 is 2 or more, two or more R 20 (s) are identical to or different from each other, when b3 is 2 or more, two or more R 30 (s) are identical to or different from each other, when b7 is 2 or more, two or more R 70 (s) are identical to or different from each other, and when b8 is 2 or more, two or more R 80 (s) are identical to or different from each other, two or more of R 1 to Rs in Formula 1 are optionally linked to form a C 5 -C 60 carbocyclic group which is unsubstituted or substituted with at least one Ria or a C 1 -C 0 heterocyclic group which is unsubstituted or substituted with at least one R 1 a, two or more of A 1 to A 7 in Formula 1 are optionally linked to form a C 5 -C 60 carbocyclic group which is unsubstituted or substituted with at least one Ria or a C 1 -C 0 heterocyclic group which is unsubstituted or substituted with at least one R 1 a, two or more of ring CY 2 , ring CY 3 , R 20 , and R 30 in Formula 2 are optionally linked to form a C 5 -C 60 carbocyclic group which is unsubstituted or substituted with at least one Ria or a C 1 -C 60 heterocyclic group which is unsubstituted or substituted with at least one R 1a , R 1a is understood by referring to the description of A 7 provided above, and a substituent of the substituted C 1 -C 60 alkyl group, the substituted C 2 -C 60 alkenyl group, the substituted C 2 -C 60 alkynyl group, the substituted C 1 -C 60 alkoxy group, the substituted C 3 -C 10 cycloalkyl group, the substituted C 2 -C 10 heterocycloalkyl group, the substituted C 3 -C 10 cycloalkenyl group, the substituted C 2 -C 10 heterocycloalkenyl group, the substituted C 6 -C 60 aryl group, the substituted C 6 -C 60 aryloxy group, the substituted C 6 -C 60 arylthio group, the substituted C 1 -C 60 heteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group is: deuterium, —F, —Cl, —Br, —I, —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —CFH 2 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, or C 1 -C 60 alkoxy group; a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, or a C 1 -C 60 alkoxy group, each substituted with deuterium, —F, —Cl, —Br, —I, —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —CFH 2 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 3 -C 10 cycloalkyl group, a C 2 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 2 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —N(Q 11 )(Q 12 ), —Si(Q 13 )(Q 14 )(Q 15 ), —Ge(Q 13 )(Q 14 )(Q 15 ), —B(Q 16 )(Q 17 ), —P(═O)(Q 18 )(Q 19 ), —P(Q 18 )(Q 19 ), or any combination thereof; a C 3 -C 10 cycloalkyl group, a C 2 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 2 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 hete

Assignees

Inventors

Classifications

  • H10K85/342Primary

    comprising iridium · CPC title

  • C09K11/06Primary

    containing organic luminescent materials · CPC title

  • Iridium compounds · CPC title

  • Polycyclic condensed aromatic hydrocarbons, e.g. anthracene · CPC title

  • containing four rings, e.g. pyrene · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11760769B2 cover?
A composition including a first compound including a compound represented by Formula 1, a second compound including a compound represented by Formula 2, and a third compound including a compound represented by Formula 3, and an organic light-emitting device including the composition: …
Who is the assignee on this patent?
Samsung Electronics Co Ltd, Samsung Sdi Co Ltd
What technology area does this patent fall under?
Primary CPC classification H10K85/342. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).